Suppr超能文献

评估用于酯酶触发醇释放的前药策略。

Evaluating prodrug strategies for esterase-triggered release of alcohols.

作者信息

Perez Christian, Daniel Kevin B, Cohen Seth M

机构信息

Department of Chemistry & Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093 (USA).

出版信息

ChemMedChem. 2013 Oct;8(10):1662-7. doi: 10.1002/cmdc.201300255. Epub 2013 Aug 8.

Abstract

Prodrugs are effective tools in overcoming drawbacks typically associated with drug formulation and delivery. Those employing esterase-triggered functional groups are frequently utilized to mask polar carboxylic acids and phenols, increasing drug-like properties such as lipophilicity. Herein we detail a comprehensive assessment for strategies that effectively release hydroxy and phenolic moieties in the presence of an esterase. Matrix metalloproteinases (MMPs) serve as our proof-of-concept target. Three distinct ester-responsive protecting groups are incorporated into MMP proinhibitors containing hydroxy moieties. Analytical evaluation of the proinhibitors demonstrates that the use of a benzyl ether group appended to the esterase trigger leads to considerably faster kinetics of conversion and enhanced aqueous stability when compared with more conventional approaches where the trigger is directly attached to the inhibitor. Biological assays confirm that all protecting groups effectively cleave in the presence of esterase to generate the active inhibitor. The superior reaction-based prodrug strategies presented here should serve as a platform for esterase-responsive prodrug design in the future.

摘要

前药是克服通常与药物制剂和递送相关缺点的有效工具。那些采用酯酶触发官能团的前药经常被用来掩盖极性羧酸和酚类,增加诸如亲脂性等类药性质。在此,我们详细评估了在酯酶存在下有效释放羟基和酚基部分的策略。基质金属蛋白酶(MMPs)作为我们的概念验证靶点。三种不同的酯响应保护基团被引入到含有羟基部分的MMP前体抑制剂中。对前体抑制剂的分析评估表明,与触发基团直接连接到抑制剂的更传统方法相比,在酯酶触发基团上附加苄基醚基团会导致转化动力学显著加快,并提高在水中的稳定性。生物学测定证实,所有保护基团在酯酶存在下均能有效裂解以产生活性抑制剂。本文提出的基于反应的卓越前药策略应成为未来酯酶响应前药设计的一个平台。

相似文献

引用本文的文献

4
Chinese medicinal herbs as potential prodrugs for obesity.作为肥胖症潜在前体药物的中草药。
Front Pharmacol. 2022 Oct 3;13:1016004. doi: 10.3389/fphar.2022.1016004. eCollection 2022.

本文引用的文献

1
Prodrugs--from serendipity to rational design.前药——从偶然发现到合理设计。
Pharmacol Rev. 2011 Sep;63(3):750-71. doi: 10.1124/pr.110.003459. Epub 2011 Jul 7.
4
Prodrugs: Some thoughts and current issues.前药:一些思考和当前问题。
J Pharm Sci. 2010 Dec;99(12):4755-65. doi: 10.1002/jps.22205.
6
Enzymatic activation of a matrix metalloproteinase inhibitor.基质金属蛋白酶抑制剂的酶激活。
Chem Commun (Camb). 2010 Feb 28;46(8):1241-3. doi: 10.1039/b923302d. Epub 2010 Jan 18.
8
Prodrugs: design and clinical applications.前体药物:设计与临床应用
Nat Rev Drug Discov. 2008 Mar;7(3):255-70. doi: 10.1038/nrd2468.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验